Brinker International Inc (NYSE:EAT) reported second-quarter FY23 revenue growth of 10% year-on-year to $1.01 billion, beating the consensus of $991.73 million.…
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Tuesday.
The Dow traded up 0.63% to 33,931.13 while the NASDAQ rose 1.20% to 11,529.99. The S&P 500 also rose, gaining, 0.93% to 4,055.00.
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new molecular entities for the year.
Several stocks have made remarkable runs since the start of the year, but famed short seller Jim Chanos expects it all to come crashing down for the bulls.